Kayla Miller
Payments from drug & device makers
Across 177 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$773
- Novo Nordisk$501
- GSK$444
- Novartis$376
- Amgen$170
- Medtronic$111
- plus $826 from 19 others
What the payments were for
- Food & beverage$3,200100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 30 | $773 |
| Novo Nordisk | 22 | $501 |
| GSK | 38 | $444 |
| Novartis | 27 | $376 |
| Amgen(2 entities) | 12 | $170 |
| Medtronic | 1 | $111 |
| Daiichi Sankyo Inc. | 6 | $110 |
| Exact Sciences | 6 | $106 |
| AbbVie | 4 | $69 |
| Lilly USA, LLC | 4 | $68 |
| Mylan Specialty L.p. | 4 | $65 |
| Dexcom, Inc. | 3 | $62 |
| Pfizer | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Sanofi Pasteur Inc. | 2 | $37 |
| Bayer | 2 | $34 |
| Boehringer Ingelheim | 2 | $28 |
| Alkermes, Inc. | 1 | $27 |
| Itamar Medical Inc | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Watermark Medical, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,200 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 53 | $68,282 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $35,141 |
| XareltoRivaroxaban | 48 | $32,333 |
| EliquisApixaban | 27 | $32,025 |
| MounjaroTirzepatide | 30 | $31,752 |
| JardianceEmpagliflozin | 29 | $29,251 |
| OzempicSemaglutide | 18 | $27,612 |
| RybelsusSemaglutide | 12 | $19,747 |
| JanuviaSitagliptin Phosphate | 27 | $16,241 |
| NexletolBempedoic Acid | 21 | $10,941 |
| MyrbetriqMirabegron | 15 | $10,539 |
| Repatha SureclickEvolocumab | 18 | $10,030 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,821 |
| TradjentaLinagliptin | 11 | $4,955 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $3,313 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $68 | $100,03483 claims |
| Novo NordiskOzempic, Rybelsus | $501 | $47,36030 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Shingrix | $444 | $43,55874 claims |
| Boehringer IngelheimJardiance, Tradjenta | $28 | $34,20740 claims |
| Johnson & JohnsonXarelto | $14 | $32,33348 claims |
| PfizerEliquis | $53 | $32,02527 claims |
| Esperion Therapeutics, Inc.Nexletol | $16 | $10,94121 claims |
| AstraZenecaSymbicort | $773 | $3,31316 claims |
| AbbVieSynthroid | $69 | $1,82221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.
Other family in Paris
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.